Key Pharmaceuticals
Australian consumer healthcare company marketing over-the-counter medicines, devices, dermocosmetics and personal care products.
- 51-200
- Macquarie Park, NSW, AU
Australian consumer healthcare company marketing over-the-counter medicines, devices, dermocosmetics and personal care products.
keypharm.com.auCrawled Oct 15, 2026
Meet Catherine Harvey, Director at Key Pharmaceuticals, and learn about their work across healthcare brands and partnerships.
Meet Helen Argiris, Director at Key Pharmaceuticals, and learn about their work across healthcare brands and partnerships.
Meet Margie Haseltine, Chair at Key Pharmaceuticals, and learn about their work across healthcare brands and partnerships.
Meet Roger Gregory, Director at Key Pharmaceuticals, and learn about their work across healthcare brands and partnerships.
Contact Key Pharmaceuticals for brand, partnership, career or customer enquiries across Australia and New Zealand.
Key Pharmaceuticals partners with healthcare brands to grow trusted consumer health products across Australia and New Zealand.
Key Pharmaceuticals collects, uses, stores and protects personal information in line with Australian privacy obligations.
Australia’s Therapeutic Goods Administration lists CYVENTINE, a cytisine 1.5 mg film-coated tablet blister pack sponsored by Key Pharmaceuticals Pty Ltd, as an active registered medicine. The ARTG entry carries registration number 522371. Retail pharmacy trade press subsequently advertises Cyventine as a pharmacist-only quit-smoking aid.
Jan 2026Therapeutic Goods Administration (ARTG)News article
Allura Partners appointed Byron Bassett as Chief Financial Officer of Key Pharmaceuticals after Meelian Hoh’s internal promotion to CEO. The search was led by Callum Jones-Bray, and Bassett previously worked at GSK, Dyson and Johnson & Johnson. The appointment is historical; Key Pharmaceuticals’ current official team page lists Helen Bourne as CFO.
Aug 2025Allura PartnersNews article
Key Pharmaceuticals celebrates 40 years of Australian ownership, having been founded in 1985 by the late Tom Gregory. The independent consumer healthcare company sells brands including Blistex, Nizoral, Hamilton, TravaCalm, EarClear, OsteVit-D and No-Doz through pharmacies, grocery retailers, health professionals and wholesalers across Australia and New Zealand; CEO Meelian Hoh cites its Key Foundation community initiative.
Jun 2025Retail Pharmacy MagazineNews article
Key Pharmaceuticals Pty Ltd sponsors OsteVit-D One-A-Week, a registered medicine containing colecalciferol 7000 IU (175 mcg) in a capsule blister pack. The TGA ARTG record includes current product information and consumer medicine information documents. The record corroborates the company's first once-a-week vitamin D3 launch, which an official partnering case study dates to 2015.
Aug 2015Therapeutic Goods Administration (ARTG)News article